Registry for collecting patient data on complex diseases
AnovaOS Network Powered Patient Registry
Anova Enterprises, Inc · NCT05013944
This study is collecting health information from people with complex diseases like cancer and diabetes to help improve treatments and understand these conditions better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Anova Enterprises, Inc (industry) |
| Locations | 1 site (Arlington Heights, Illinois) |
| Trial ID | NCT05013944 on ClinicalTrials.gov |
What this trial studies
The AnovaOS Network Powered Patient Registry aims to develop and manage a comprehensive database that captures real-world data on various complex diseases, including infectious diseases, cancers, and metabolic disorders. This registry will facilitate the collection of clinically meaningful information regarding diagnosis, treatment, and outcomes. It is designed to support the development of clinical trials and observational studies, enhancing the understanding and management of these conditions. Participants will be asked to provide data annually to maintain updated records.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults aged 18 and older with a confirmed diagnosis of a complex disease.
Not a fit: Patients who do not have a confirmed diagnosis or are unable to provide informed consent may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could significantly improve the understanding and treatment of complex diseases by providing valuable insights from real-world patient data.
How similar studies have performed: Other patient registries have shown success in improving disease understanding and treatment outcomes, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years old or older; * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative; * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials; * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements; * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy; * Anticipated additional follow up with the registry once per year. Exclusion Criteria: * Subjects who do not meet the inclusion criteria for the study; * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
Where this trial is running
Arlington Heights, Illinois
- Anova Enterprises, Inc. — Arlington Heights, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Christopher Beardmore — Anova Enterprises, Inc
- Study coordinator: Christopher Beardmore
- Email: chris@anovaevidence.com
- Phone: +1 (224) 218-2408
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infectious Disease, Neoplasms, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism, Endocrine, Nutritional and Metabolic Diseases, Mental and Behavioural Disorders, Diseases of the Nervous System, Diseases of the Eye and Adnexa, Diseases of the Ear and Mastoid Process